– USA, OH – Invacare Corporation (NYSE: IVC) today announced the appointment of Aron Schwartz to its Board of Directors, effective March 21, 2022, bringing a wide range of financial experience in managing and overseeing companies across multiple industries, including companies undergoing strategic transformation.
His appointment brings the number of Invacare directors to a total of nine, eight of whom are independent.
“We are pleased to further strengthen our Board with the addition of Aron. His depth and breadth of financial and operational experience will be invaluable to Invacare as we continue to drive our business transformation and enhance our profitability,” said Chairman and CEO, Matt Monaghan.
Mr. Schwartz will also join the Audit Committee and the Nominating and Governance Committee.
About Aron I. Schwartz
Mr. Schwartz currently serves as Managing Partner of ACON Investments, a private equity firm based in Washington, D.C. Prior to joining ACON Investments in 2014, Mr. Schwartz served as Managing Director of Avenue Capital, a global investment firm, from 2012 to 2014, and before that, he held various positions culminating in Managing Director of Fenway Partners. He also serves on the board of directors and chairs the audit committee of CION Investment Corporation (NYSE: CION), a business development company that primarily provides senior secured lending facilities to middle-market companies.
“I am excited to join Invacare’s Board of Directors and work with the board and management team to help drive sustainable growth and solidify the company’s leadership position. I am proud to be working with a company which provides vital medical devices that help improve the daily lives of so many people around the world,” said Mr. Schwartz.
About Invacare Corporation
Invacare Corporation is a leading manufacturer and distributor in its markets for medical equipment used in non-acute care settings. At its core, the company designs, manufactures, and distributes medical devices that help people to move, breathe, rest and perform essential hygiene. The company provides clinically complex medical device solutions for congenital (e.g., cerebral palsy, muscular dystrophy, spina bifida), acquired (e.g., stroke, spinal cord injury, traumatic brain injury, post-acute recovery, pressure ulcers) and degenerative (e.g., ALS, multiple sclerosis, chronic obstructive pulmonary disease, elderly, bariatric) ailments. The company’s products are important parts of care for people with a wide range of challenges, from those who are active and involved in work or school each day and may need additional mobility or respiratory support, to those who are cared for in residential care settings, at home, and in rehabilitation centers. The company sells its products principally to home medical equipment providers with retail and e-commerce channels, residential care operators, distributors, and government health services in North America, Europe, and Asia/Pacific.
For more information: https://na.invacare.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.